info iconCurrently, the share price for GlaxoSmithKline Pharmaceuticals Ltd. is delayed.

close icon
GlaxoSmithKline Pharmaceuticals Ltd. Logo

GlaxoSmithKline Pharmaceuticals Ltd.

₹2,238.35
NSE
--   ( -- %) 1D



  • Prev. Close
    2,238.35
  • Upper Circuit
    2,686.00
  • Lower Circuit
    1,790.70

Returns

GlaxoSmithKline Pharmaceuticals Ltd.'s Info & Management

GlaxoSmithKline Pharmaceuticals is engaged inter alia, in the business of manufacturing, distributing and trading in pharmaceuticals.
  • Executive Director,Whole Time Director,Chief Financial Officer
    J. Chandy
  • Vice President(Real Estate,Administration),Company Secretary
    A A Nadkarni
  • Executive Vice President(Regulatory Affairs)
    Ms. S. Choudhary
  • Executive Vice President(Communications,Government Affairs)
    R. D'Souza
  • Executive Vice President(Medical)
    Dr. (Ms.) R. Hegde
  • Executive Vice President(Vaccines)
    S. Mukherjee

FAQs on GlaxoSmithKline Pharmaceuticals Ltd.

What is the share price of GlaxoSmithKline Pharmaceuticals Ltd.?

GlaxoSmithKline Pharmaceuticals Ltd. share price is ₹2,160.00 as of February 22, 2024, 01:50 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of GlaxoSmithKline Pharmaceuticals Ltd.?

The 52-week high and low of GlaxoSmithKline Pharmaceuticals Ltd. is ₹2,523.00 and ₹1,227.00 respectively as of February 22, 2024, 01:50 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of GlaxoSmithKline Pharmaceuticals Ltd.?

The trailing twelve month (TTM) PB ratio of GlaxoSmithKline Pharmaceuticals Ltd. is 21.80 as of February 22, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of GlaxoSmithKline Pharmaceuticals Ltd.?

The Upper Circuit of GlaxoSmithKline Pharmaceuticals Ltd. is ₹2,686. The Lower Circuit of GlaxoSmithKline Pharmaceuticals Ltd. is ₹1,791.

What is the ROE of GlaxoSmithKline Pharmaceuticals Ltd.?

GlaxoSmithKline Pharmaceuticals Ltd. reported an ROE of 35.41% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of GlaxoSmithKline Pharmaceuticals Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for GlaxoSmithKline Pharmaceuticals Ltd., Promoter held 75%, the FII held 2.9%, DII held 8.6% and the public held 13.4% of the total shares.

How to buy GlaxoSmithKline Pharmaceuticals Ltd. Share?

You can easily buy shares of GlaxoSmithKline Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of GlaxoSmithKline Pharmaceuticals Ltd.?

The fair value of GlaxoSmithKline Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer